This comprehensive guide details critical quality control (QC) metrics and analytical frameworks specifically tailored for single-cell RNA sequencing (scRNA-seq) data in stem cell research.
This article provides a comprehensive evaluation of methods for preserving and verifying cellular identity, a critical challenge in cell-based therapies and single-cell genomics.
This article provides a comprehensive guide for researchers and drug development professionals on managing batch variation in autologous cell products.
Allogeneic cell therapies derived from healthy donors or induced pluripotent stem cells (iPSCs) offer transformative potential for treating cancer, diabetes, and autoimmune diseases by providing 'off-the-shelf' availability.
Allogeneic cell therapies offer a scalable, 'off-the-shelf' alternative to autologous treatments but face significant barriers from host immune rejection and graft-versus-host disease (GvHD).
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on establishing a robust contamination control strategy (CCS) for cell therapy manufacturing.
This article provides a comprehensive analysis of non-relapse mortality (NRM) following hematopoietic stem cell transplantation, contrasting the significantly higher risks associated with allogeneic (allo-SCT) versus autologous (auto-SCT) procedures.
This article provides a comprehensive analysis of cell expansion protocols for autologous and allogeneic therapies, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of the manufacturing processes for autologous and allogeneic cell therapies, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of the application of Pharmacokinetic-Pharmacodynamic (PK-PD) correlation modeling in natural product research.